Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10255-1 GSK1838705A LSM-4276 25182616
10252-1 Gemcitabine
Gemzar
LSM-5333 60750
10251-1 Fascaplysin LSM-4272 73293
10250-1 Etoposide LSM-6348 36462
10249-1 Epirubicin
Ellence
LSM-2078 41867
10248-1 Doxorubicin
Adriamycin
LSM-4062 31703
10247-1 Docetaxel
Taxotere
LSM-6360 148124
10246-1 CPT-11
Irinotecan
LSM-2167 60838
10245-1 Cisplatin
CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat
LSM-4268
10244-1 CGC-11144 LSM-4267 6476700
10243-1 CGC-11047
PG11047
LSM-4266 476863
10242-1 Carboplatin LSM-44959 5237030
10241-1 Bortezomib
Velcade
LSM-6281 387447
10238-1 5-FU
Fluorouracil
LSM-4261 3385
10237-1 5-DFUR
5-FdUR; Doxifluridine
LSM-6359 18343
10236-1 17-AAG
Tanespimycin
LSM-43239 151069
10235-2 Everolimus
RAD001
LSM-4258 53398658
10230-2 Lestaurtinib
CEP-701
LSM-1231 126565
10228-2 IKK16 LSM-2309 9549298
10223-2 AG1478
Tyrphostin
LSM-1224 2051
10189-2 Bosutinib
SKI-606
LSM-1190 5328940
10175-3 Sunitinib
Sutent; SU11248
LSM-42800 3086686
10172-2 GSK1059615 LSM-1173 71317162
10146-2 Omipalisib
GSK2126458; GSK2126458A
LSM-1147 25167777
10142-2 Trametinib
GSK-1120212; GSK1120212; GSK1120212B; JTP-74057
LSM-1143 11707110